Requirement of mitogen-activated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide

J Immunol. 2001 Mar 1;166(5):3423-31. doi: 10.4049/jimmunol.166.5.3423.

Abstract

In the present study, we evaluated the ability of GPI-anchored mucin-like glycoproteins purified from Trypanosoma cruzi trypomastigotes (tGPI-mucin) to trigger phosphorylation of different mitogen-activated protein kinases (MAPKs) and related transcription factors in inflammatory macrophages. Kinetic experiments show that the peak of extracellular signal-related kinase (ERK)-1/ERK-2, stress-activated protein kinase (SAPK) kinase-1/mitogen-activated protein kinase (MAPK) kinase-4, and p38/SAPK-2, phosphorylation occurs between 15 and 30 min after macrophage stimulation with tGPI-mucin or GPI anchors highly purified from tGPI-mucins (tGPI). The use of the specific inhibitors of ERK-1/ERK-2 (PD 98059) and p38/SAPK-2 (SB 203580) phosphorylation also indicates the role of MAPKs, with possible involvement of cAMP response element binding protein, in triggering TNF-alpha and IL-12 synthesis by IFN-gamma-primed-macrophages exposed to tGPI or tGPI-mucin. In addition, tGPI-mucin and tGPI were able to induce phosphorylation of I kappa B, and the use of SN50 peptide, an inhibitor of NF-kappa B translocation, resulted in 70% of TNF-alpha synthesis by macrophages exposed to tGPI-mucin. Finally, the similarity of patterns of MAPK and I kappa B phosphorylation, the concentration of drugs required to inhibit cytokine synthesis, as well as cross-tolerization exhibited by macrophages exposed to tGPI, tGPI-mucin, or bacterial LPS, suggest that receptors with the same functional properties are triggered by these different microbial glycoconjugates.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 2
  • Animals
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Cytokines / biosynthesis*
  • Enzyme Activation / drug effects
  • Enzyme Activation / immunology
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Glycosylphosphatidylinositols / metabolism*
  • I-kappa B Proteins / metabolism*
  • Imidazoles / pharmacology
  • Immune Tolerance / drug effects
  • Inflammation / immunology
  • Interleukin-12 / biosynthesis
  • Lipopolysaccharides / immunology
  • Lipopolysaccharides / pharmacology*
  • MAP Kinase Kinase 4*
  • Macrophage Activation / drug effects
  • Macrophages / drug effects
  • Macrophages / enzymology*
  • Macrophages / immunology
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred C57BL
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 8
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / metabolism*
  • Mucins / immunology
  • NF-kappa B / physiology
  • Nitric Oxide / biosynthesis
  • Phosphorylation / drug effects
  • Protozoan Proteins / immunology
  • Pyridines / pharmacology
  • Receptors, Cell Surface / physiology*
  • Transcription Factors / metabolism
  • Trypanosoma cruzi / immunology*
  • Tumor Necrosis Factor-alpha / biosynthesis
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Activating Transcription Factor 2
  • Cyclic AMP Response Element-Binding Protein
  • Cytokines
  • Enzyme Inhibitors
  • Flavonoids
  • Glycosylphosphatidylinositols
  • I-kappa B Proteins
  • Imidazoles
  • Lipopolysaccharides
  • Mucins
  • NF-kappa B
  • Protozoan Proteins
  • Pyridines
  • Receptors, Cell Surface
  • TgPI protein, Toxoplasma gondii
  • Transcription Factors
  • Tumor Necrosis Factor-alpha
  • glycolipid receptor
  • Interleukin-12
  • Nitric Oxide
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 8
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4
  • Map2k4 protein, mouse
  • Mitogen-Activated Protein Kinase Kinases
  • SB 203580
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one